The health department has informed pharmaceutical manufacturers that they will be permitted an above-inflation 6.79% hike for private sector medicine sales in 2024, offering drugmakers some relief from rising input costs, but piling pressure on cash-strapped consumers and medical schemes.

The SA Reserve Bank put inflation at 5.8% in November and expects it to average 5% in 2024...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.